Brief: Syros Reports Fourth Quarter And Full Year 2021 Financial Results

Syros Pharmaceuticals

15/03/2022 11:36

March 15 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL
RESULTS AND HIGHLIGHTS KEY ACCOMPLISHMENTS AND UPCOMING
MILESTONES
    * Q4 LOSS PER SHARE $0.38
    * Q4 REVENUE $7.8 MILLION
    * Q4 REVENUE VIEW $4.8 MILLION -- REFINITIV IBES DATA
    * SYROS PHARMACEUTICALS - BELIEVES EXISTING CASH, CASH
EQUIVALENTS
ARE SUFFICIENT TO FUND REQUIREMENTS INTO Q1 OF 2023

Source text for Eikon:  ID:nBw6kF6Vda 
Further company coverage:  SYRS.O